Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2531-2534

  Zhu, Wu Ling ^a   Fan, Bing Lin ^a   Liu, Dong Liang ^b   Zhu, Wen Xiao ^c  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b Zhengzhou Central Hospital   (China)

^c HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Clinical stage; Fibrinogen; Fibrinogen gamma; Hepatocellular carcinoma; Tumor thrombosis

Indexed keywords

FIBRINOGEN; FIBRINOGEN GAMMA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER GROWTH; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR THROMBUS; UPREGULATION;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; FEMALE; FIBRINOGEN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 69249170029     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mosesson MW: Fibrinogen and fibrin structure and functions. J Thromb Haemost 3(8): 1894-1904, 2005.
2. Redman CM and Xia H: Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann N Y Acad Sci 936: 480-495, 2001.
3. Felding-Habermann B, Ruggeri ZM and Cheresh DA: Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 267(8): 5070-5077, 1992.
4. Yokoyama K, Zhang XP, Medved L and Takada Y: Specific binding of integrin alpha íbeta 3 to the fibrinogen gamma and alpha E chain C-terminal domains. Biochemistry 38(18): 5872-5877, 1999. (Pubitemid 29220609)
5. Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro-Cacho CA and Yeatman TJ: Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res 66(5): 2592-2599, 2006.
6. Wang Q, Xie R and Zhang QY: Clinical significance of plasma fibrinogen level in patients with colorectal cancer. Zhonghua Zhong Liu Za Zhi 27(9): 544-546, 2005 (in Chinese).
7. Ma Y, Qian Y and Lv W: The correlation between plasma fibrinogen levels and the clinical features of patients with ovarian carcinoma. J Int Med Res 35(5): 678-684, 2007 (Pubitemid 47570488)
8. Xin Chen, Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D and Brown PO: Gene expression patterns in human liver cancers. Mol Biol Cell 13(6): 1929-1939, 2002.
9. Pérez-Carreón JI, López-García C, Fattel-Fazenda S, Arce-Popoca E, Alemán-Lazarini L, Hernández- García S, Le Berre V, Sokol S, Francois JM and Villa-Treviñio S: Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats. Neoplasia 8(5): 373-383, 2006.
10. Zhu WL, Duan FL, Liu DL, Fan BL, Zhang L, Gao TH and Chen XY: Cloning the genes differently expressed in human hepatocellular carcinoma by suppression subtractive hybridization. Zhonghua Gan Zang Bing Za Zhi 11(3): 183-184, 2003 (in Chinese).
11. Zhu WL, Cheng HX, Han N, Liu DL, Zhu WX, Fan BL and Duan FL: Messenger RNA expression of translationally controlled tumor protein (TCTP) in liver regeneration and cancer. Anticancer Res 28(3): 1575-1580, 2008. (Pubitemid 351892932)
12. Takizawa D, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, Katakai K, Kojima A, Matsuzaki Y and Mori M: Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 52(11): 3290-3295, 2007. (Pubitemid 47512562)
13. Battistelli S, Stefanoni M, Lorenzi B, Dell'avanzato R, Varrone F, Pascucci A, Petrioli R and Vittoria A: Coagulation factor levels in non-metastatic colorectal cancer patients. Int J Biol Markers 23(1): 36-41, 2008.
14. Lee JH, Ryu KW, Kim S and Bae JM: Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology 51(60): 1860-1863, 2004.